Alaunos Therapeutics (TCRT)
(Delayed Data from NSDQ)
$1.12 USD
-0.11 (-8.94%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $1.14 +0.02 (1.79%) 5:44 PM ET
NA Value
NA Growth NA Momentum NA VGMIndustry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 38% (96 out of 250)Zacks Sector Rank
Top 19% (3 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 3.00 | 1.35 | 9.99 |
Current Quarter Estimate | NA | 7.43 | 60.00 |
Year Ago Quarter Estimate | -0.60 | 0.12 | 52.54 |
Next Quarter Estimate | NA | 7.81 | 61.00 |
Next Year Estimate | NA | 37.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | NA | 10.20 | 17.10 |
Next Year | NA | 13.80 | 8.00 |
Last 5 Years | NA | 5.90 | 8.10 |
Next 5 Years | NA | 22.10 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.18 |
Price/Book (MRQ) | 3.13 | 1.87 |
Price/Cash Flow (MRFY) | NA | 9.05 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -19.76% |
Return on Equity (TTM) | -196.96% | -72.91% |
Debt to Equity (MRQ) | NA | 0.30 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.